Evaluating the Safety, Tolerability, and Pharmacokinetics of an Investigational, Injectable HIV Medicine (GSK1265744) in HIV-Uninfected Adults

NCT02178800 · clinicaltrials.gov ↗

PHASE2

Phase

COMPLETED

Status

199

Enrollment

NIH

Sponsor class

Conditions

HIV Infections

Interventions

DRUG: GSK1265744 Tablets
DRUG: Injectable GSK1265744
DRUG: Placebo for GSK1265744 Tablets
DRUG: Injectable Placebo for GSK1265744

Sponsor

National Institute of Allergy and Infectious Diseases (NIAID)